FOI2021/00469: Ivermectin as a Covid-19 treatment
Case reference FOI2021/00469
Published 1 February 2022
Request
Request Received: 26 October 2021
I'm interested in the use of Ivermectin in Covid-19 Recovery Trial(s) and the selection of treatments included in the Trial(s). Therefore, under the Freedom of Information Act legislation, I have the following questions:
1) Has Ivermectin ever been considered for addition to the Recovery Trial(s)?
2) Please send me any documents relating to why Ivermectin so far not been included in the Recovery Trial(s)?
(Note: I'm particularly interested in any summary conclusions which led to any decision not to).
3) Please send me any documents you hold that consider the strong positive evidence about the use of Ivermectin as a treatment for Covid that has emerged from Systematic Reviews, Cochrane Systematic Reviews, Trials, and other evidence from across the world.
Response
Response Sent: 9 November 2021
Full details of this response are provided in the attached documents.
Documents
This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.